Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method

Abstract : Several antimalarial drugs are known to prolong ventricular repolarization as evidenced by QT/QTc interval prolongation. This can lead to Torsades de Pointes, a potentially lethal ventricular arrhythmia. Whether this is the case with artemisinin-based combination therapies (ACTs) remains uncertain. Assessment of the extent of QTc prolongation with antimalarials is hampered by important variations of heart rate during malaria crises and previous studies have reported highly variable values of QTc prolongations with ACTs. We assessed QTc prolongation with four ACTs, using high quality ECG recording and measurement techniques, during the first episode of malaria in 2,091 African patients enrolled in the WANECAM study which also monitored clinical safety. Using an original and robust method of QTc assessment, independent from heart rate changes and from the method of QT correction, we were able to accurately assess the extent of mean maximum QTc prolongation with the four ACTs tested. There was no evidence of proarrhythmia with any treatment during the study although dihydroartemisinin-piperaquine, artesunate-amodiaquine and artemether-lumefantrine significantly prolonged QTc. The extent of prolongation of ventricular repolarization can be accurately assessed in studies where heart rate changes impede QTc assessment.
Complete list of metadatas

Cited literature [32 references]  Display  Hide  Download

https://hal.sorbonne-universite.fr/hal-02017652
Contributor : Gestionnaire Hal-Su <>
Submitted on : Wednesday, February 13, 2019 - 11:55:09 AM
Last modification on : Saturday, March 23, 2019 - 1:38:15 AM
Long-term archiving on : Tuesday, May 14, 2019 - 6:51:15 PM

File

s41598-018-37113-5(1).pdf
Publication funded by an institution

Identifiers

Citation

Christian Funck-Brentano, Nouhoum Ouologuem, Stephan Duparc, Mathieu Felices, Sodiomon Sirima, et al.. Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method. Scientific Reports, Nature Publishing Group, 2019, 9, pp.883. ⟨10.1038/s41598-018-37113-5⟩. ⟨hal-02017652⟩

Share

Metrics

Record views

40

Files downloads

18